164 related articles for article (PubMed ID: 37834839)
1. Preventive and Therapeutic Effect of Metformin in Head and Neck Cancer: A Concise Review.
Bouland C; Vanden Eynden X; Lalmand M; Buset T; Yanni A; Javadian R; Rodriguez A; Loeb I; Lechien JR; Journe F; Saussez S; Dequanter D
J Clin Med; 2023 Sep; 12(19):. PubMed ID: 37834839
[TBL] [Abstract][Full Text] [Related]
2. Diabetes mellitus, metformin and head and neck cancer.
Figueiredo RA; Weiderpass E; Tajara EH; Ström P; Carvalho AL; de Carvalho MB; Kanda JL; Moyses RA; Wünsch-Filho V
Oral Oncol; 2016 Oct; 61():47-54. PubMed ID: 27688104
[TBL] [Abstract][Full Text] [Related]
3. Survival impact and toxicity of metformin in head and neck cancer: An analysis of the SEER-Medicare dataset.
Stokes WA; Eguchi M; Amini A; Hararah MK; Ding D; McDermott JD; Bradley CJ; Karam SD
Oral Oncol; 2018 Sep; 84():12-19. PubMed ID: 30115470
[TBL] [Abstract][Full Text] [Related]
4. Protective effects of metformin, statins and anti-inflammatory drugs on head and neck cancer: A systematic review.
Saka Herrán C; Jané-Salas E; Estrugo Devesa A; López-López J
Oral Oncol; 2018 Oct; 85():68-81. PubMed ID: 30220322
[TBL] [Abstract][Full Text] [Related]
5. Survival Benefit of Metformin as an Adjuvant Treatment for Head and Neck Cancer: A Systematic Review and Meta-Analysis.
Jiao Y; Liu D; Sun Y; Chen Z; Liu S
Front Pharmacol; 2022; 13():850750. PubMed ID: 35645803
[No Abstract] [Full Text] [Related]
6. Metformin exposure and survival in head and neck cancer: A large population-based cohort study.
Alcusky M; Keith SW; Karagiannis T; Rabinowitz C; Louis DZ; Maio V
J Clin Pharm Ther; 2019 Aug; 44(4):588-594. PubMed ID: 31293011
[TBL] [Abstract][Full Text] [Related]
7. Prognostic value of diabetes and metformin use in a real-life population of head and neck cancer patients.
De Falco V; Vitale P; Brancati C; Cicero G; Auriemma A; Addeo R
Front Med (Lausanne); 2023; 10():1252407. PubMed ID: 37746082
[TBL] [Abstract][Full Text] [Related]
8. Nutrition impact symptoms and associated outcomes in post-chemoradiotherapy head and neck cancer survivors: a systematic review.
Crowder SL; Douglas KG; Yanina Pepino M; Sarma KP; Arthur AE
J Cancer Surviv; 2018 Aug; 12(4):479-494. PubMed ID: 29556926
[TBL] [Abstract][Full Text] [Related]
9. Effects of metformin on head and neck cancer: a systematic review.
Rêgo DF; Pavan LM; Elias ST; De Luca Canto G; Guerra EN
Oral Oncol; 2015 May; 51(5):416-22. PubMed ID: 25636350
[TBL] [Abstract][Full Text] [Related]
10. Metformin and the risk of head and neck cancer: a case-control analysis.
Becker C; Jick SS; Meier CR; Bodmer M
Diabetes Obes Metab; 2014 Nov; 16(11):1148-54. PubMed ID: 25041125
[TBL] [Abstract][Full Text] [Related]
11. Smartphone-based follow-up of upper airway symptoms in head and neck cancer survivors one year after radiation therapy.
Muñoz-Vigueras N; Obeso-Benítez P; Jerviz-Guía V; Rodríguez-Torres J; Granados-Santiago M; López-López L; Valenza MC
Int J Lang Commun Disord; 2023 Mar; 58(2):270-278. PubMed ID: 36114794
[TBL] [Abstract][Full Text] [Related]
12. Targeting BCAA metabolism to potentiate metformin's therapeutic efficacy in the treatment of diabetes in mice.
Zhao X; Zhang X; Pei J; Liu Y; Niu W; Sun H
Diabetologia; 2023 Nov; 66(11):2139-2153. PubMed ID: 37581618
[TBL] [Abstract][Full Text] [Related]
13. Landscape assessment for gender neutral human papillomavirus vaccination recommendations including head and neck cancer burden data.
Morais E; El Mouaddin N; Schuurman S; De A
Vaccine; 2021 Sep; 39(39):5461-5473. PubMed ID: 34452775
[TBL] [Abstract][Full Text] [Related]
14. Metformin Prevents the Progression of Dysplastic Mucosa of the Head and Neck to Carcinoma in Nondiabetic Patients.
Lerner MZ; Mor N; Paek H; Blitzer A; Strome M
Ann Otol Rhinol Laryngol; 2017 Apr; 126(4):340-343. PubMed ID: 28103701
[TBL] [Abstract][Full Text] [Related]
15. Therapeutic exercises for affecting post-treatment swallowing in people treated for advanced-stage head and neck cancers.
Perry A; Lee SH; Cotton S; Kennedy C
Cochrane Database Syst Rev; 2016 Aug; 2016(8):CD011112. PubMed ID: 27562477
[TBL] [Abstract][Full Text] [Related]
16. The Association between Metformin and Survival of Head and Neck Cancer: A Systematic Review and Meta-Analysis of 7 Retrospective Cohort Studies.
Wang Y; Fu T; Liu Y; Yang G; Yu C; Zhang ZJ
Curr Pharm Des; 2020; 26(26):3161-3170. PubMed ID: 32067604
[TBL] [Abstract][Full Text] [Related]
17. Metformin Inhibits Progression of Head and Neck Squamous Cell Carcinoma by Acting Directly on Carcinoma-Initiating Cells.
Wu X; Yeerna H; Goto Y; Ando T; Wu VH; Zhang X; Wang Z; Amornphimoltham P; Murphy AN; Tamayo P; Chen Q; Lippman SM; Gutkind JS
Cancer Res; 2019 Sep; 79(17):4360-4370. PubMed ID: 31292160
[TBL] [Abstract][Full Text] [Related]
18. Metformin suppresses growth of human head and neck squamous cell carcinoma via global inhibition of protein translation.
Sikka A; Kaur M; Agarwal C; Deep G; Agarwal R
Cell Cycle; 2012 Apr; 11(7):1374-82. PubMed ID: 22421144
[TBL] [Abstract][Full Text] [Related]
19. Role of sarcopenia on survival and treatment-related toxicity in head and neck cancer: a narrative review of current evidence and future perspectives.
Erul E; Guven DC; Onur MR; Yazici G; Aksoy S
Eur Arch Otorhinolaryngol; 2023 Aug; 280(8):3541-3556. PubMed ID: 37188907
[TBL] [Abstract][Full Text] [Related]
20. Rehabilitation Interventions for Shoulder Dysfunction in Patients With Head and Neck Cancer: Systematic Review and Meta-Analysis.
Almeida KAM; Rocha AP; Carvas N; Pinto ACPN
Phys Ther; 2020 Oct; 100(11):1997-2008. PubMed ID: 32750136
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
